Vera Therapeutics, Inc.
VERA
$34.19
-$1.09-3.09%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -401.90M | -368.95M | -299.62M | -251.94M | -218.28M |
| Total Depreciation and Amortization | 536.00K | 523.00K | 468.00K | 388.00K | 283.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 63.83M | 56.53M | 35.05M | 29.36M | 23.65M |
| Change in Net Operating Assets | -1.12M | 18.70M | 22.99M | 11.90M | 9.08M |
| Cash from Operations | -338.65M | -293.20M | -241.10M | -210.29M | -185.27M |
| Capital Expenditure | -258.00K | -466.00K | -630.00K | -1.17M | -1.28M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 45.73M | 41.62M | 194.92M | -106.59M | -137.93M |
| Cash from Investing | 45.47M | 41.15M | 194.29M | -107.76M | -139.21M |
| Total Debt Issued | 0.00 | 23.34M | 23.34M | 23.34M | 23.34M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 310.84M | 309.39M | 306.98M | 350.11M | 350.06M |
| Repurchase of Common Stock | -- | -- | -- | 0.00 | -13.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -17.91M | -21.42M | -21.42M | -24.87M | -24.87M |
| Cash from Financing | 292.94M | 311.31M | 308.90M | 348.57M | 348.51M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -245.00K | 59.26M | 262.08M | 30.52M | 24.04M |